MIRA INFORM REPORT

 

 

Report Date :

12.04.2014

 

IDENTIFICATION DETAILS

 

Name :

IRIS HEALTHCARE TECHNOLOGIES PRIVATE LIMITED

 

 

Registered Office :

C-103/104, Sagar Garden, LBS Marg, Mulund West, Mumbai – 400080, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

04.01.2008

 

 

Com. Reg. No.:

11-180697

 

 

Capital Investment / Paid-up Capital :

Rs.15.000 Millions

 

 

CIN No.:

[Company Identification No.]

U85100MH2008PTC180697

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, importers, exporters, dealers, agents and/or suppliers of clinical diagnostics reagents and analysers, laboratory chemicals and analysers, analytical instruments and devices, hospital products. Surgical and scientific apparatus.    

 

 

No. of Employees :

Information denied by management

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 172000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Reserve of the company seems to be low.

 

However, the rating reflects improved financial risk profile marked by fair profitability levels and sound capital base of the company.

 

Trade relations are fair. Business is active. Payment terms are reported to be slow but correct.

 

The company can be considered for business dealings at usual trade terms and condition. 

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit for the fiscal third quarter ended September 2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9 billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and moderation in gold imports. Manufacturing activity and new orders in India showed their strongest growth in a year in February. The news comes as a relief after data showed Asia’s third largest economy grew by a slower-than-expected 4.7 % annually in the three months through December. The HSBC Manufacturing Purchasing Managers’ Index which gauges the business activity of India’s factories but not its’ utilities, rose to 52.5 in February, its highest in a year from 51.4 in January. Overall new orders for factory goods which rose to a one-year high of 54.9 contributed to the surge. China has emerged as India’s biggest trading partner in the current financial year replacing the United Arab Emirates and pushing it to the third spot. India-China trade has reached $49.5 billion with a 8.7 % share in India’s total trade. The US comes second at $46 billion with 8.1 % share during the first nine months of the current financial year.

 

The Reserve Bank of India has granted an additional nine months to the public to exchange currency notes printed before 2005 including Rs 500 and Rs 1,000 denominations, pushing the deadline to January 1, 2015. A day before dates for the Lok Sabha polls were announced, the government decided to hike interest rates on fixed deposit schemes offered by post offices up to 0.2 per cent. The new rates will be effective April, 1. The Supreme Court will resume hearing on March, 11 Nokia’s appeal against a ruling over transferring ownership of its local mobile phones plant which is the subject of a tax dispute to Microsoft Corp.

 

In the last days of the current Government, another scam has surfaced. The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The Central Bureau of Investigation will look into allegations that over $80 million was paid in kickbacks in a deal signed in 2011. India has asked Boeing Co. to find a solution for problems with state-owned Air India’s 787 Dreamliners. The aircraft has experienced a series of malfunctions since its debut in 2011.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 


 

INFORMATION DENIED BY

 

Name :

Mr. Suhas

Designation :

Accounts Manager

Contact No.:

91-22-25921625

Date :

09.04.2014

 

 

LOCATIONS

 

Registered Office :

C-103/104, Sagar Garden, LBS Marg, Mulund West, Mumbai – 400080, Maharashtra, India 

Tel. No.:

91-22-25921625 / 25921626

Fax No.:

91-22-25921627

E-Mail :

sreeram.gopal@iris-healthcare.com

info@iris-healthcare.com

Website :

www.iris-healthcare.com

 

 

DIRECTORS

 

As on 25.09.2013

 

Name :

Mr. Sreeram Gopal

Designation :

Director

Address :

704, 1th Floor, B Wing, Swapna Nagar, Mulund West, Mumbai – 400080, Maharashtra, India

Date of Birth/Age :

20.09.1968

Date of Appointment :

01.04.2008

DIN No.:

00134716

 

 

Name :

Mrs. Vijaylakshmi Subramanian

Designation :

Director

Address :

Sai Vignesh Nivas No.8, Fourth Street, Ganapathy Nagar, Anakaputhur, Chennai – 600070, Tamilnadu, India 

Date of Birth/Age :

12.09.1969

Date of Appointment :

01.04.2008

DIN No.:

01766590

 

 

KEY EXECUTIVES

 

Name :

Sudhanwa S Kalamkar and Associates

Designation :

Company Secretary

Address :

B-1/12, Vijay Wadi Niwas CHS Limited, Lokmanya Tilak Road, Mulund East, Mumbai – 400081, Maharashtra, India

Tel. No.:

91-22-25633027 / 3047

 

 

Name :

Mr. Suhas

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS

 

As on 25.09.2013

 

Names of Shareholders

No. of Shares

% of Holding

Sreeram Gopal

300000

20.00

Indra Chemicals Private Limited

825000

55.00

P. Sri Hari

135000

9.00

Sarita Thadhani

45000

3.00

Sandeep Debroy

45000

3.00

Srinivasan T

45000

3.00

Sushanta Senn

45000

3.00

S Padmaja Reddy

60000

4.00

Total

1500000

100.00

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 25.09.2013

 

Category

Percentage

Bodies corporate

55.00

Directors or relatives of Directors

20.00

Other top fifty shareholders

25.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, importers, exporters, dealers, agents and/or suppliers of clinical diagnostics reagents and analysers, laboratory chemicals and analysers, analytical instruments and devices, hospital products. Surgical and scientific apparatus.    

 

 

GENERAL INFORMATION

 

No. of Employees :

Information denied by management

 

 

Bankers :

  • Canara Bank, Mulund Camp Branch, Mulund East, Mumbai - 400080, Maharashtra, India
  • HDFC Bank Limited, HDFC Bank House Senapati Bapat Marg, Lower Parel West, Mumbai - 400013, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Short Term Borrowings

 

 

Loans repayable on demand

 

 

From Bank

36.382

13.567

Total

36.382

13.567

 

 

 

Banking Relations :

--

 

 

Financial Institutions :

Siemens Financial Services Private Limited, 130, Pandurang Budhkar Marg, Worli, Mumbai – 400018, Maharashtra, India

 

 

Auditors :

 

Name :

R. Shrinivas

Chartered Accountants

ADDRESS :

Flat No. 9, Abirami Royale, # 73, 1st Avenue, Indire Nagar, Chennai – 600020, Tamilnadu, India

Tel. No.:

91-22-25633027 / 3047

PAN No.:

AAGPS00116D

 


 

CAPITAL STRUCTURE

 

As on 25.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Millions


Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Millions

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

15.000

10.000

0.100

(b) Reserves & Surplus

5.260

0.128

(12.040)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

22.615

16.965

26.865

Total Shareholders’ Funds (1) + (2)

42.875

27.093

14.925

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

1.369

0.000

0.000

(c) Other long term liabilities

6.350

12.075

10.750

(d) long-term provisions

1.793

1.314

0.000

Total Non-current Liabilities (3)

9.512

13.389

10.750

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

36.382

13.567

9.463

(b) Trade payables

26.777

25.650

43.694

(c) Other current liabilities

10.308

13.759

10.250

(d) Short-term provisions

4.437

5.376

3.397

Total Current Liabilities (4)

77.904

58.352

66.804

 

 

 

 

TOTAL

130.291

98.834

92.479

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

5.760

3.046

2.717

(ii) Intangible Assets

6.413

6.774

7.116

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

2.583

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

1.952

1.365

1.528

Total Non-Current Assets

16.708

11.185

11.361

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

33.305

30.555

30.875

(c) Trade receivables

74.428

53.194

46.601

(d) Cash and cash equivalents

1.369

0.391

0.327

(e) Short-term loans and advances

4.481

3.509

3.315

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

113.583

87.649

81.118

 

 

 

 

TOTAL

130.291

98.834

92.479

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

 

 

Other Income

 

 

 

 

 

TOTAL                                         (A)

246.934

181.044

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                         (B)

236.907

162.166

NA

 

 

 

 

 

Less

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

10.027

18.878

NA

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

4.399

2.669

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

5.628

16.209

NA

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

0.787

0.669

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

4.841

15.540

NA

 

 

 

 

 

Less

TAX                                                                  (H)

(0.291)

3.372

NA

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

5.132

12.168

2.583

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

0.128

(12.040)

(14.623)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

5.260

0.128

(12.040)

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.42

NA

NA

 

 


KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

2.08

6.72

NA

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

1.96

8.58

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

3.79

15.72

NA

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.11

0.57

NA

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.85

0.50

0.63

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.46

1.50

1.21

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

0.100

10.000

15.000

Reserves & Surplus

(12.040)

0.128

5.260

Share Application money pending allotment

26.865

16.965

22.615

Net worth

14.925

27.093

42.875

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

9.463

13.567

36.382

Total borrowings

9.463

13.567

36.382

Debt/Equity ratio

0.634

0.501

0.849

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Sales

 

181.044

246.934

 

 

 

36.394

 

 

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Sales

 

181.044

246.934

Profit

 

12.168

5.132

 

 

6.72%

2.08%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

 No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

 No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

 No

15]

Capital in the business

Yes

16]

Details of sister concerns

 No

17]

Major suppliers

 No

18]

Major customers

 No

19]

Payments terms

 No

20]

Export / Import details (if applicable)

 No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

BACKGROUND:

 

The company was incorporated o 1st April 2008 with the main object to carry on the business as manufacturer, importers, exporters, dealers, agents and/or suppliers of clinical diagnostics reagents and analysers, laboratory chemicals and analysers, analytical instruments and devices, hospital products. Surgical and scientific apparatus.    

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U85100MH2008PTC180697

Name of the company

IRIS Healthcare Technologies Private Limited

Address of the registered office or of the principal place of  business in India of the company

C-103/104, Sagar Garden, LBS Marg, Mulund West, Mumbai – 400080, Maharashtra, India

This form is for

Creation of charge

Type of charge

Movable property (not being pledge)

Particular of charge holder

Siemens Financial Services Private Limited, 130, Pandurang Budhkar Marg, Worli, Mumbai – 400018, Maharashtra, India

Nature of instrument creating charge

Loan agreement and hypothecation agreement

Date of instrument Creating the charge

28.02.2014

Amount secured by the charge

Rs.3.123 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

14.50% p.a.

 

Terms of Repayment

Repayable in 36 months

 

Margin

Contributed by borrower

 

Extent and Operation of the charge

First and exclusive charge of Siemens Financial Services Private Limited on asset financed vide agreement dated 28.02.2014. asset details as mentioned in point no.15

Short particulars of the property or asset(s) charged (including complete address and location of the property)

1 no. of Siemens ADVIA Centaur XP Immunoassay system (refurb) with all its accessories- Sl no.: IRL77710707-Installed at Dr. Remedies Labs,A3,Sharma Complex, Titus Plaza, Dwarakpuri Lane, Punjagutta, Hyderabad, Andhra Pradesh, India

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.27

UK Pound

1

Rs.101.10

Euro

1

Rs.83.74

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.